First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Hits New 12-Month High – Should You Buy?

Shares of First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) reached a new 52-week high during trading on Monday . The stock traded as high as $248.15 and last traded at $246.9920, with a volume of 530704 shares changing hands. The stock had previously closed at $246.96.

First Trust NYSE Arca Biotechnology Index Fund Stock Performance

The business’s 50-day moving average is $216.93 and its two-hundred day moving average is $210.66. The stock has a market capitalization of $2.79 billion, a PE ratio of 21.72 and a beta of 0.68.

Hedge Funds Weigh In On First Trust NYSE Arca Biotechnology Index Fund

A number of large investors have recently modified their holdings of the company. Dynamic Wealth Strategies LLC raised its holdings in First Trust NYSE Arca Biotechnology Index Fund by 10.8% in the fourth quarter. Dynamic Wealth Strategies LLC now owns 515 shares of the company’s stock valued at $106,000 after buying an additional 50 shares during the period. Sequent Planning LLC increased its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 4.5% in the first quarter. Sequent Planning LLC now owns 1,150 shares of the company’s stock worth $231,000 after acquiring an additional 50 shares in the last quarter. Kestra Private Wealth Services LLC increased its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 0.6% in the fourth quarter. Kestra Private Wealth Services LLC now owns 8,919 shares of the company’s stock worth $1,842,000 after acquiring an additional 53 shares in the last quarter. Signaturefd LLC raised its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 30.6% in the 4th quarter. Signaturefd LLC now owns 235 shares of the company’s stock valued at $49,000 after acquiring an additional 55 shares during the period. Finally, Bedell Frazier Investment Counselling LLC raised its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 1.8% in the 3rd quarter. Bedell Frazier Investment Counselling LLC now owns 3,200 shares of the company’s stock valued at $574,000 after acquiring an additional 57 shares during the period.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.